Publications:

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.

Ebiomedicine

Sun, Hao H; Liu, Si-Yang SY; Zhou, Jia-Ying JY; Xu, Jin-Tian JT; Zhang, Huang-Kai HK; Yan, Hong-Hong HH; Huan, Jiao-Jiao JJ; Dai, Ping-Ping PP; Xu, Chong-Rui CR; Su, Jian J; Guan, Yan-Fang YF; Yi, Xin X; Yu, Rong-Shan RS; Zhong, Wen-Zhao WZ; Wu, Yi-Long YL

Publication Date: 2020-10

Variant appearance in text: KIT: 1468G>C; Glu490Gln

PubMed Link: 32927274

Variant Present in the following documents:

• mmc2.xlsx, sheet 1

View BVdb publication page

Prospective Comprehensive Molecular Characterization of Lung Adenocarcinomas for Efficient Patient Matching to Approved and Emerging Therapies.

Cancer Discovery

Jordan, Emmet J EJ; Kim, Hyunjae R HR; Arcila, Maria E ME; Barron, David D; Chakravarty, Debyani D; Gao, JianJiong J; Chang, Matthew T MT; Ni, Andy A; Kundra, Ritika R; Jonsson, Philip P; Jayakumaran, Gowtham G; Gao, Sizhi Paul SP; Johnsen, Hannah C HC; Hanrahan, Aphrothiti J AJ; Zehir, Ahmet A; Rekhtman, Natasha N; Ginsberg, Michelle S MS; Li, Bob T BT; Yu, Helena A HA; Paik, Paul K PK; Drilon, Alexander A; Hellmann, Matthew D MD; Reales, Dalicia N DN; Benayed, Ryma R; Rusch, Valerie W VW; Kris, Mark G MG; Chaft, Jamie E JE; Baselga, José J; Taylor, Barry S BS; Schultz, Nikolaus N; Rudin, Charles M CM; Hyman, David M DM; Berger, Michael F MF; Solit, David B DB; Ladanyi, Marc M; Riely, Gregory J GJ

Publication Date: 2017-06

Variant appearance in text: KIT: E490Q

PubMed Link: 28336552

Variant Present in the following documents:

• Main text

View BVdb publication page